Opiate-Induced Tolerance & Hyperalgesia in Pain Patients

Status Completed

Clinical Trial Summary

Opiates such as morphine are the cornerstone medications for the treatment of moderate to severe pain. Recent evidence suggests that pain patients on chronic opioid therapy become more sensitive to pain (hyperalgesia) over time. There is also a long-standing notion that analgesic tolerance to opioids (habituation) develops during chronic use even though this phenomenon has never been prospectively studied. Our specific aims propose to prospectively test the hypotheses that; 1) Pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) Opioid-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) Opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) Opioid-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity. This proposed study will be the first quantitative and prospective study of tolerance and hyperalgesia in pain patients and will have important implications for the rational use of opioids in the treatment of chronic pain.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00246532
Study type	Interventional
Source	National Institute of General Medical Sciences (NIGMS)
Contact
Status	Completed
Phase	Phase 4
Start date	October 2005
Completion date	August 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03243084` - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy	N/A
Suspended	`NCT04735185` - Stem Cells vs. Steroids for Discogenic Back Pain	N/A
Completed	`NCT03162952` - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed	`NCT03240146` - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain	N/A
Completed	`NCT05282589` - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients	N/A
Completed	`NCT03637998` - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain	N/A
Recruiting	`NCT02289170` - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)	N/A
Active, not recruiting	`NCT01944163` - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain	N/A
Completed	`NCT02231554` - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial	N/A
Recruiting	`NCT02063503` - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients	N/A
Terminated	`NCT01620775` - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain	N/A
Completed	`NCT01704677` - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up	N/A
Completed	`NCT01177280` - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes	N/A
Completed	`NCT01490905` - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain	Phase 4
Completed	`NCT01177241` - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids	N/A
Completed	`NCT01177254` - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions	N/A
Completed	`NCT00984815` - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment	Phase 3
Completed	`NCT00761150` - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	Phase 3
Completed	`NCT00767806` - A Study for Patient With Chronic Low Back Pain	Phase 3
Completed	`NCT00763321` - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)	Phase 3